Pfizer Inc.’s vaccine to protect against a potentially dangerous respiratory infection will be offered to about three million ...

RSV is a common virus that infects the lungs. While symptoms are mild for many people, the virus can be severe in older adults, causing pneumonia, bronchitis and flare-ups of existing lung disease and ...

A European panel has backed expanding the RSV vaccine from adults aged 60 years or older to all adults aged 18 years or older.

RSV vaccine cuts hospital admissions by 75 in Welsh over-75s, says Public Health Wales. Programme expands to over-80s.

RSV vaccine cuts hospital admissions by 75% in Welsh over-75s, says Public Health Wales. Programme expands to over-80s.

RSV vaccination is recommended for all adults age 75 and older, but only about 40% received a vaccine by the end of the ...

In an interview with the CBC's Amy Smith, Nova Scotia's deputy chief medical officer of health breaks down the numbers and ...

The vaccine was previously approved in the US to prevent LRTD related to RSV infection in adults 60 years or older and high-risk adults aged 50-59 years but remains contraindicate ...

RSV, influenza and a new Cicada COVID variant are on the rise. But which one do you have? Here's the differences ...

While the most common time for viruses is from fall to the beginning of spring, one virus is sticking around for just a ...

The first year of P.E.I.’s expanded RSV program has been a success, with hospitalizations for the virus dropping by nearly ...

FDA has expanded approval of Arexvy (RSV vaccine, adjuvanted) to include prevention of LRTD caused by RSV in at-risk adults aged 18 to 49.